Urogen Pharma Ltd. (URGN)
Market Closed
16 Oct, 08:00 PM
$
34. 56
-2.05
-5.5996%
After Hours
$
+5.44 +15.7407% 40. 00
1.79B Market Cap
- P/E Ratio
- Div Yield
1.05M Volume
-3.56 Eps
$ 36.61
Previous Close 
Want to track URGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Urogen Pharma Ltd. (URGN) Statistics
Valuation metrics
Market Cap 1.79B
Enterprise value 1.91B
Trailing P/E (ttm) -18.6
Forward P/E 20.03
PEG ratio -0.37
Price/Sales (ttm) 9.51
Price/Book (mrq) -14.01
Enterprise Value/Revenue 10.13
Enterprise Value/EBITDA -27.26
Overview
Shares outstanding 48.35M
Float 38.71M
Shares short 7.24M
% Held by insiders 0.04%
% Held by institutions 0.98%
Average volume (10 days) 1.51M
Average volume (90 days) 1.02M
Price summary
52-Week low 16.36
52-Week high 50.81
Beta 1.59
50-Day moving average 41.31
200-Day moving average 30.1
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -0.52%
Operating margin -0.35%
Operational effectiveness
Return on assets -0.39%
Return on equity 0.82%
Income Statement
Revenue (ttm) 140.49M
Revenue per share (ttm) 3.75
Quarterly revenue growth (yoy) 1.52%
Gross profit (ttm) 126.24M
EBITDA -107.9M
Net income to common (ttm) -133.22M
Diluted EPS (ttm) -1.94
Quarterly earnings growth (yoy) 0.54%
Balance Sheet
Total cash (mrq) 140.27M
Total cash per share (mrq) 2.14
Total debt (mrq) 197.09M
Total Debt/Equity (mrq) -1.48
Current ratio (mrq) 3.8%
Book value per share (mrq) -2.63
Cash Flow
Cash flow statement -165.74M
Levered free cash flow (LFCF) -109.28M
2026 © Marketlog. All Rights Reserved.
